De Novo Software, a leading provider of flow cytometry data analysis and reporting solutions, announced today the release of the next version of their flagship product line, FCS Express™ – to customers in clinical, research and pharmaceutical markets worldwide. David Novo, De Novo Software’s president said: “The new version was completely rewritten to support multi-core […]
Enabling access to the latest laboratory technologies without the full initial outlay Amersham Place, Chalfont UK. – GE Healthcare, a unit of General Electric Company (NYSE: GE) today announced Key Equipment Finance, a global, bank-held equipment finance company and an affiliate of KeyCorp (NYSE: KEY), as European equipment finance partner to enable customers to access […]
Strasbourg, France – Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, announces the completion of a funding round in which it raised EUR 2.5 million. This new round brings in new shareholders in Polyplus-transfection, AIRFI (Alsace Inter Regio Fonds d’Investissement) and Sudinnova, which […]
PALO ALTO, Calif. – StemCells, Inc. (Nasdaq:STEM) announced today that it has entered into an agreement to sell ten million shares of its common stock to selected institutional investors at a price of $1.00 per share, which represents a 10% discount to the closing price per share of January 6. The offering is expected to […]
Horizon Discovery (Horizon) a leading provider of research tools to support the development of personalized medicines, and the University of Washington (UW) announced today that they have entered into a two-year research collaboration aimed at generating a process for gene editing in inducible human pluripotent stem cells. The research will exploit the high efficiency and […]
Darmstadt, Germany – Merck KGaA announced today that it has acquired 100% of the share capital of Beijing Skywing Technology Co., Ltd., a leading supplier of cell-culture media products, related technical services and bioreactors for the Chinese biopharmaceutical industry. The company is headquartered in the Changping district of Beijing and currently employs 80 people. The […]
LEXINGTON, Ky. -Transposagen Biopharmaceuticals, Inc. (Transposagen), a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International (CDI), the world’s largest producer of human induced pluripotent stem (iPS) cell lines and tissue cells for drug discovery and safety. The license agreement allows CDI to use […]
YOKOHAMA, Japan – ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) announces today that the company will enter a collaborative R&D agreement with the National Institute of Biomedical Innovation (NIBIO; Director General: Koichi Yamanishi; Osaka, Japan), which could offer new hepatocyte derived from human iPS (induced pluripotent stem) cells used for an effective in-vitro drug screening for […]
ALAMEDA, Calif. – BioTime, Inc. (NYSE Amex: BTX) today announced a material transfer agreement (MTA) with the University of California (UC) system to make five research-grade human embryonic stem (hES) cell lines available to UC system researchers. These lines are genetically identical to a bank of GMP-compliant hES cell lines that will be made available […]
Mannheim, Germany – Leica Microsystems has effectively matched the Leica TCS SP5 MP multiphoton microscope with a fully integrated OPO (Optical Parametric Oscillator) solution. The integration of the Coherent Chameleon Compact OPO with the Leica TCS SP5 MP confocal and multiphoton microscope allows observation of fast dynamic processes in living cells with deep penetration at […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
